$AGRIC-ALT-PROTEIN-RESEARCH

104th Regular Session Introduced by Paul Faraci and 1 co-sponsor

Illinois would provide a $1 million state grant to the University of Illinois to expand biomanufacturing and alternative protein research at the IBRL.

Overview

Bill number & session: SB4069, 104th General Assembly, Illinois

Introduced: February 24, 2026

Sponsor: Sen. Mattie Hunter (primary); Co-sponsors Sen. Paul Faraci

Purpose: Provide state funding to expand biomanufacturing and alternative protein research at the University of Illinois’ integrated bioprocessing research laboratory (IBRL)

Key Provisions

Funding amount: Appropriates $1,000,000 (one million dollars)

Source of funds: General Revenue Fund

Recipient: University of Illinois

Authorized use: For the expansion of biomanufacturing and alternative protein research and development at the University’s Integrated Bioprocessing Research Laboratory (IBRL)

Effective date: July 1, 2026

What the Bill Would Change/Provide

Establishes a dedicated state grant of $1 million to support:

Expansion activities at the IBRL
Research and development initiatives focused on biomanufacturing and alternative proteins

Signals Illinois’ interest in advancing non-traditional protein sources and bioprocessing technologies, potentially including cultivated or plant-based proteins, fermentation-based production, and related process improvements.

Who/What is Affected

Primary beneficiary: University of Illinois (through funding for IBRL initiatives)

Indirect beneficiaries:

Illinois residents and the state economy via potential growth in biomanufacturing, innovation, and workforce development
Stakeholders in the agricultural, biotechnology, and alternative protein sectors who may benefit from research outputs and accelerated technology transfer

Procedural and Timeline Aspects

Bill status: Introduced and referred; added as Chief Co-Sponsor later

Funding timing: Appropriation, if enacted, would be available as of the fiscal year beginning July 1, 2026

Implementation: Requires no other accompanying amendments beyond the appropriation language; execution details (project scopes, reporting, or milestones) are not specified in the text provided and would presumably be set by University-led project plans and any implementing state department guidance

Remarks

The bill is narrowly focused on a single appropriation intended to bolster Illinois’ capabilities in biomanufacturing and alternative protein research at a major public university.

As introduced, it does not specify performance metrics, reporting requirements, or matching funds, which could be addressed in subsequent committee discussions or amendments.

If you would like, I can add a brief comparison to prior Illinois funding for similar programs or outline potential policy and economic impacts based on typical outcomes of such appropriations.

Bill